Animal Sedatives Market Size
Animal Reversives Rising pet ownership, expanding surgical operations in animals, increasing incidence of zoonotic diseases, increasing adoption of pet insurance, increasing animal healthcare expenditure, and growing investment in veterinary product development activities mean that market size, valued USD 145.4 million in 2022, is expected to experience a sustainable rise of CAGR 5.5% up to 2032.
To get key market trends
An animal sedative is a medicine or pharmacological agent used to induce or soothe in animals a condition of drowsiness. Targeting the central nervous system, they assist to reduce its activity, therefore producing a relaxing impact on animals. In animals, they serve to lower tension and anxiety, thereby enabling their cooperation and management during veterinary treatments, operations, dental work, or disease diagnostics.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Animal Sedatives Market Size in 2022 | USD 145.4 Million |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 5.5% |
| 2032 Value Projection | USD 247.2 Million |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 256 |
| Tables, Charts & Figures | 444 |
| Segments covered | Drug class, Route of administration, Application, Animal type, and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
What are the growth opportunities in this market?
Lockdowns, social distance rules, and prioritizing of essential services during the epidemic caused many veterinary hospitals and clinics to temporarily close or operate with less activity. Under such circumstances, the veterinary clinics let just severe veterinary cases attend them. As a result, non-emergency veterinary operations dropped, which finally helped to lower the general demand for animal sedatives. The epidemic disturbed the animal health sector among other sectors of the supply chain. Many veterinary hospitals and clinics thus ran out of basic supplies including drugs, pet food, or safety gear.
Conversely, the COVID-19 epidemic led a notable increase in pet ownership. A lot of people yearned for company during lockdowns, which drove up pet adoption. The market for animal healthcare has benefited generally from rising pet ownership. The growing frequency of animal diseases drives need for quicker and more effective diagnostic and treatment solutions.
Animal Sedatives Driving Factors
One of the main forces guiding the development of the animal sedative industry is growing pet ownership. For example, the UK Pet Food Manufacturer's Association estimates that around 62% of UK homes have some sort of animal. Among them, estimates of the cat population ranged from 12 million to 13 million and the dog population from 13 million to People's awareness and worry for their pets and animal welfare following the epidemic drives demand for veterinary services as well.
Growing need for animal diagnostics and surgical treatments in animals in order to offer improved treatment outcomes came from the rising frequency of animal diseases. Rising surgical and diagnostic procedures, growing zoonotic disease incidence, and more attention on animal health and expenditure are among the elements influencing these developments.
Animal Sedatives Market Analysis
The animal sedatives market is divided according on medication class into phenothiazines, alpha-2 adrenergic receptor agonists, benzodiazepines, butyrophenones, and other pharmacological classes. With 39.4% of the industry's share in 2022 the phenothiazines sector will be the largest. In tiny animals, they offer antiemetic, muscle relaxing, and sedative properties. For dogs and cats, these are the most often used and potent animal sedatives. Among the most often prescribed members of the phenothiazine class of sedatives is acepromazine. One can give this family of drugs orally or parenterally.
Learn more about the key segments shaping this market
The animal sedatives market is split depending on route of administration into oral and parenteral. By 2032 the paredteral segment should demonstrate value at a CAGR of 5%. Sedatives given parenterally help to guarantee a faster and more consistent absorption into the bloodstream. It guarantees control over dosage for exact administration of sedatives and assists in the fast beginning of action. It improves the bioavailability of sedatives, so ensuring enough and higher absorption of them.
The animal sedatives market is categorized depending on use into surgical, diagnostic, clinical research, and other uses. The surgical procedures segment is expected to have worth USD 59.2 million in 2022. Commonly used in veterinary medications to ease animal surgical operations are the sedatives. They make animals controllable and easy to handle while they help in lowering their nervousness and terror, thereby facilitating the surgical operations. They guarantee staff and animal safety and help them to relax.
Learn more about the key segments shaping this market
Based on animal type, the animal sedatives market is subdivided into small animals and large animals. The small animal segment is further subdivided into dogs, cats, and other small animals. The large animal segment is further subdivided into cattle, horses, and other large animals. The small animal segment comprised of the largest market share of 73.9%, in 2022. The key factors supporting the expansion of this segment are the rapidly increasing pet ownership, the high prevalence of zoonotic diseases, the increasing adoption of pet insurance, and the increasing need of diagnostics and adequate treatment.
Based on distribution channel, the animal sedatives market is classified into hospital pharmacies, retail pharmacies, and other distribution channels. The hospital pharmacies segment held the largest market share of 52.9% in 2022. The increasing prevalence of zoonotic diseases, the growing need of diagnostics, the increasing number of visits to veterinary hospitals and clinics, and the increasing number of veterinary practitioners.
Looking for region specific data?
Based on the region, In 2022, the North American animal sedatives market is expected to reach USD 103.4 million by 2032. This is because of a significant population of pets, well-established veterinary infrastructure, high utilization of animal sedatives for a wide range of applications, including diagnosis, surgical procedures, or animal handling, and increasing animal healthcare expenditure. On the other hand, the Asia Pacific industry is expected to grow at the highest CAGR of 6% by 2032.
Animal Sedatives Market Share
The prominent players in animal sedatives market are
- Zoetis Inc
- Elanco Animal Health Incorporated
- Virbac
- Dechra Pharmaceuticals plc
- Orion Corporation
- Ceva Animal Health
- Bayer AG
- Chanelle Pharma
- Merck & Co. Inc
- Boehringer Ingelheim Animal Health.
Animal Sedatives Industry News
- In March 2022, the U.S. FDA approved Zenalpha (medetomidine and vatinoxan hydrochlorides injection) by Dechra Pharmaceuticals plc as a sedative for dogs that can sedate and make them comfortable while undergoing exams or certain medical procedures leading to product enhancement.
- In September 2022, Zoetis acquired Jurox Pty Limited for developing, manufacturing, and selling animal health products, leading to growth in sales and revenue of the company.
The global animal sedatives market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
By Drug Class
- Phenothiazines
- Alpha-2 adrenergic receptor agonist
- Benzodiazepines
- Butyrophenones
- Other drug classes
By Route of Administration
- Parenteral
- Oral
By Application
- Surgical procedures
- Diagnostic procedures
- Clinical research studies
- Other applications
By Animal Type
- Small animals
- Dogs
- Cats
- Other small animals
- Large animals
- Cattles
- Horses
- Other large animals
By Distribution Channel
- Hospital pharmacies
- Retail pharmacies
- Other distribution channels
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of Middle East & Africa
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy